Search Results - "Repousis, Panagiotis"

Incidence, clinical features, laboratory findings and outcome of patients with multiple myeloma presenting with extramedullary relapse.

Authors: Papanikolaou, Xenofon Repousis, Panagiotis Tzenou, Tatiana et al.

Source: Leukemia & Lymphoma. Jul2013, Vol. 54 Issue 7, p1459-1464. 6p.

Pomalidomide Plus Low-Dose Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients: Results of the Real-World "POWERFUL" Study.

Authors: Terpos, Evangelos Repousis, Panagiotis Lalayanni, Chrysavgi et al.

Source: Journal of Clinical Medicine. Apr2021, Vol. 10 Issue 7, p1509. 1p.

Aggressive T‐Cell Large Granular Lymphocyte Leukemia With the Unusual Double‐Negative CD4−/CD8−/TCRαβ+ Phenotype; Report of Two Cases and Review of the Literature.

Authors: Kotsiafti, Angeliki Tsagarakis, Nikolaos J. Vadikolia, Chrissa M. et al.

Source: International Journal of Laboratory Hematology. Dec2025, Vol. 47 Issue 6, p1202-1205. 4p.

The prognostic significance of chromosome 17 abnormalities in patients with myelodysplastic syndrome treated with 5‐azacytidine: Results from the Hellenic 5‐azacytidine registry.

Authors: Diamantopoulos, Panagiotis Koumbi, Dafni Kotsianidis, Ioannis et al.

Source: Cancer Medicine. May2019, Vol. 8 Issue 5, p2056-2063. 8p.

Immunoglobulin D myeloma: clinical features and outcome in the era of novel agents.

Authors: Zagouri, Flora Kastritis, Efstathios Symeonidis, Argiris S. et al.

Source: European Journal of Haematology. Apr2014, Vol. 92 Issue 4, p308-312. 5p.

Multiple myeloma in octogenarians: Clinical features and outcome in the novel agent era.

Authors: Dimopoulos, Meletios A. Kastritis, Efstathios Delimpasi, Sossana et al.

Source: European Journal of Haematology. Jul2012, Vol. 89 Issue 1, p10-15. 6p. 2 Charts, 3 Graphs.

The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.

Authors: Diamantopoulos, Panagiotis T. Symeonidis, Argiris Pappa, Vasiliki et al.

Source: British Journal of Haematology. Mar2021, Vol. 192 Issue 6, p978-987. 10p.

Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience.

Authors: Katodritou, Eirini Terpos, Evangelos Kastritis, Efstathios et al.

Source: Annals of Hematology. Dec2015, Vol. 94 Issue 12, p2033-2042. 10p.

Outcomes of Hodgkin’s Lymphoma Patients with Relapse or Progression following Autologous Hematopoietic Cell Transplantation

Authors: Kaloyannidis, Panayotis Voutiadou, Georgia Baltadakis, Ioannis et al.

Source: Biology of Blood & Marrow Transplantation. Mar2012, Vol. 18 Issue 3, p451-457. 7p.

High levels of serum angiogenic growth factors in patients with AL amyloidosis: comparisons with normal individuals and multiple myeloma patients.

Authors: Kastritis, Efstathios Roussou, Maria Michael, Michalis et al.

Source: British Journal of Haematology. Sep2010, Vol. 150 Issue 5, p587-591. 5p. 1 Chart, 1 Graph.

Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry.

Authors: Diamantopoulos PT Pappa V Symeonidis A et al.

Source: Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2020 Feb; Vol. 20 (2), pp. 114-121. Date of Electronic Publication: 2019 Sep 28.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101525386 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2152-2669 (Electronic) Linking ISSN: 21522669 NLM ISO Abbreviation: Clin Lymphoma Myeloma Leuk Subsets: MEDLINE

Long term remissions, late relapses and prolonged survival in patients with multiple myeloma before the era of novel agents.

Authors: Megalakaki, Aikaterini Lampropoulou, Polyxeni Giannakas, Konstantinos et al.

Source: Clinical lymphoma, myeloma & leukemia Oct2019 Supplement; Vol. 19.

Journal Info: Publisher: Elsevier B.V. ISSN: 2152-2650

Lenalidomide (Len) Refractory MM Patients' Outcomes.

Authors: Gkioka, Annita Ioanna Repousis, Panagiotis Rougkala, Niki et al.

Source: Clinical lymphoma, myeloma & leukemia Oct2019 Supplement; Vol. 19.

Journal Info: Publisher: Elsevier B.V. ISSN: 2152-2650

Prognostic value and clinical correlations of serum cereblon (CRBN) levels in multiple myeloma patients treated with Lenalidomide/Dexamethasone (RD).

Authors: Gkioka, Annita Ioanna Repousis, Panagiotis Papaioannou, Paraskevi et al.

Source: Clinical lymphoma, myeloma & leukemia Oct2019 Supplement; Vol. 19.

Journal Info: Publisher: Elsevier B.V. ISSN: 2152-2650

Floating Carotid Thrombus in a Patient With Essential Thrombocytemia due to Calreticulin Mutation.

Authors: Psychogios K Kargiotis O Safouris A et al.

Source: Stroke [Stroke] 2023 May; Vol. 54 (5), pp. e207-e208. Date of Electronic Publication: 2023 Mar 13.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0235266 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4628 (Electronic) Linking ISSN: 00392499 NLM ISO Abbreviation: Stroke Subsets: MEDLINE

Integrating multi-disciplinary discussion in clinical practice.

Authors: Papanikolaou IC Afthinos A Papoudou-Bai A et al.

Source: Advances in respiratory medicine [Adv Respir Med] 2019; Vol. 87 (6), pp. 274-276.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101697329 Publication Model: Print Cited Medium: Internet ISSN: 2543-6031 (Electronic) Linking ISSN: 24514934 NLM ISO Abbreviation: Adv Respir Med Subsets: MEDLINE

The outcome of patients with high-risk MDS achieving stable disease after treatment with 5-azacytidine: A retrospective analysis of the Hellenic (Greek) MDS Study Group.

Authors: Papageorgiou SG Kontos CK Kotsianidis I et al.

Source: Hematological oncology [Hematol Oncol] 2018 Oct; Vol. 36 (4), pp. 693-700. Date of Electronic Publication: 2018 Sep 07.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

Positive impact of brentuximab vedotin on overall survival of patients with classical Hodgkin lymphoma who relapse or progress after autologous stem cell transplantation: A nationwide analysis.

Authors: Tsirigotis P Vassilakopoulos T Batsis I et al.

Source: Hematological oncology [Hematol Oncol] 2018 Oct; Vol. 36 (4), pp. 645-650. Date of Electronic Publication: 2018 Jun 08.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

Brentuximab vedotin in relapsed/refractory Hodgkin lymphoma. The Hellenic experience.

Authors: Angelopoulou MK Vassilakopoulos TP Batsis I et al.

Source: Hematological oncology [Hematol Oncol] 2018 Feb; Vol. 36 (1), pp. 174-181. Date of Electronic Publication: 2017 Feb 20.

Publication Type: Journal Article; Multicenter Study

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE

Re-evaluation of prognostic markers including staging, serum free light chains or their ratio and serum lactate dehydrogenase in multiple myeloma patients receiving novel agents.

Authors: Maltezas D Dimopoulos MA Katodritou I et al.

Source: Hematological oncology [Hematol Oncol] 2013 Jun; Vol. 31 (2), pp. 96-102. Date of Electronic Publication: 2012 Sep 07.

Publication Type: Journal Article

Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8307268 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1069 (Electronic) Linking ISSN: 02780232 NLM ISO Abbreviation: Hematol Oncol Subsets: MEDLINE